- Added to Email Alerts
Antiretroviral Therapy
Latest News View All
-
IAS 2021HIV Acquisition on PrEP Rare, With Some Drug Resistance -
Liver Cancer Monotherapy Indication for Nivolumab Withdrawn
-
HIV: Failed viral suppression in CAB/RPV linked to 3 Risk Factors
-
IAS 2021Younger Adults With HIV Have Higher CVD Risk but Low ASCVD Scores
-
Dolutegravir Confirmed as Effective Second-Line HIV Therapy
-
IAS 2021Lenacapavir Shows Viral Suppression in Drug-Resistant HIV
-
IAS 2021HIV: Could Another Two-Drug Regimen Be on the Horizon?
-
AstraZeneca-Oxford Vaccine Protective Against COVID-19 in People With HIV
Perspective View All
Journal Articles View All
-
Predictors of HIV-1 Virologic Failure to CAB and RPV
-
P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke
-
Switching to DTG plus bDRV in Treatment-Experienced HIV-1
-
The Burden of Non-Communicable Diseases, Mortality in PLHIV
-
Outcomes Associated With Change From TDF to TAF in HIV-1
-
eGFR in HIV and HCV-coinfected Patients Receiving DAAs+ART
Additional Resources
Medscape Drugs & Diseases
- Antiretroviral Therapy for HIV Infection
- Cutaneous Manifestations of HIV Disease
- HIV Disease
- HIV in Pregnancy
- Pediatric HIV Infection
Medscape Education